BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...
BEIJING--(BUSINESS WIRE)-- Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, ...
Feb.10 -- Hong Kong Food and Health Secretary Sophia Chan discusses the government's Covid-19 vaccination rollout plan and the efforts to fight the pandemic. She speaks with Rishaad Salamat and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results